VIGL
Ensign Peak Advisors’s Vigil Neuroscience VIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,578,116
| Closed | -$2.81M | – | 1720 |
|
|
2025
Q1 | $2.81M | Buy |
1,578,116
+875,000
| +124% | +$1.56M | 0.01% | 787 |
|
|
2024
Q4 | $1.2M | Buy |
703,116
+97,580
| +16% | +$166K | ﹤0.01% | 1209 |
|
|
2024
Q3 | $2.06M | Buy |
605,536
+210,420
| +53% | +$715K | ﹤0.01% | 938 |
|
|
2024
Q2 | $1.58M | Buy |
395,116
+166,442
| +73% | +$666K | ﹤0.01% | 1014 |
|
|
2024
Q1 | $780K | Hold |
228,674
| – | – | ﹤0.01% | 1475 |
|
|
2023
Q4 | $773K | Buy |
228,674
+216,750
| +1,818% | +$733K | ﹤0.01% | 1518 |
|
|
2023
Q3 | $64.3K | Buy |
+11,924
| New | +$64.3K | ﹤0.01% | 1747 |
|